223 related articles for article (PubMed ID: 27819744)
41. Correlation of GSTP1 gene variants of male Iraqi waterpipe (Hookah) tobacco smokers and the risk of lung cancer.
Kudhair BK; Alabid NN; Taheri-Kafrani A; Lafta IJ
Mol Biol Rep; 2020 Apr; 47(4):2677-2684. PubMed ID: 32125559
[TBL] [Abstract][Full Text] [Related]
42. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
43. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
[TBL] [Abstract][Full Text] [Related]
44. A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups.
Sengupta D; Banerjee S; Mukhopadhyay P; Mitra R; Chaudhuri T; Sarkar A; Bhattacharjee G; Nath S; Roychoudhury S; Bhattacharjee S; Sengupta M
Sci Rep; 2021 Jul; 11(1):14572. PubMed ID: 34272429
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms and endometriosis: a systematic review and meta-analyses.
Méar L; Herr M; Fauconnier A; Pineau C; Vialard F
Hum Reprod Update; 2020 Jan; 26(1):73-102. PubMed ID: 31821471
[TBL] [Abstract][Full Text] [Related]
46. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215
[TBL] [Abstract][Full Text] [Related]
47. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.
Le Morvan V; Bellott R; Moisan F; Mathoulin-Pélissier S; Bonnet J; Robert J
Pharmacogenomics; 2006 Sep; 7(6):843-52. PubMed ID: 16981845
[TBL] [Abstract][Full Text] [Related]
48. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
49. DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India.
Pramanik S; Devi S; Chowdhary S; Surendran ST; Krishnamurthi K; Chakrabarti T
Chemosphere; 2011 Feb; 82(7):941-6. PubMed ID: 21183201
[TBL] [Abstract][Full Text] [Related]
50. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
[TBL] [Abstract][Full Text] [Related]
51. DNA repair gene polymorphisms do not predict response to radiotherapy-based multimodality treatment of patients with rectal cancer: a meta-analysis.
Guo CX; Yang GP; Pei Q; Yin JY; Tan HY; Yuan H
Asian Pac J Cancer Prev; 2015; 16(2):713-8. PubMed ID: 25684513
[TBL] [Abstract][Full Text] [Related]
52. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
53. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
54. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
55. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Yang LM; Li XH; Bao CF
Asian Pac J Cancer Prev; 2012; 13(11):5883-6. PubMed ID: 23317281
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
57. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.
Manuguerra M; Saletta F; Karagas MR; Berwick M; Veglia F; Vineis P; Matullo G
Am J Epidemiol; 2006 Aug; 164(4):297-302. PubMed ID: 16707649
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms and mutations in GSTP1, RAD51, XRCC1 and XRCC3 genes in breast cancer patients.
Al Zoubi MS; Zavaglia K; Mazanti C; Al Hamad M; Al Batayneh K; Aljabali AAA; Bevilacqua G
Int J Biol Markers; 2017 Jul; 32(3):e337-e343. PubMed ID: 28315507
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
60. DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients.
Cifci S; Yilmaz M; Pehlivan M; Sever T; Okan V; Pehlivan S
Hematology; 2011 Nov; 16(6):361-7. PubMed ID: 22183071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
